Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 594

1.

Luteinizing hormone regulates the phosphorylation and localization of the mitochondrial effector dynamin-related protein-1 (DRP1) and steroidogenesis in the bovine corpus luteum.

Plewes MR, Hou X, Talbott HA, Zhang P, Wood JR, Cupp AS, Davis JS.

FASEB J. 2020 Feb 20. doi: 10.1096/fj.201902958R. [Epub ahead of print]

PMID:
32077149
2.

Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.

Tong SYC, Lye DC, Yahav D, Sud A, Robinson JO, Nelson J, Archuleta S, Roberts MA, Cass A, Paterson DL, Foo H, Paul M, Guy SD, Tramontana AR, Walls GB, McBride S, Bak N, Ghosh N, Rogers BA, Ralph AP, Davies J, Ferguson PE, Dotel R, McKew GL, Gray TJ, Holmes NE, Smith S, Warner MS, Kalimuddin S, Young BE, Runnegar N, Andresen DN, Anagnostou NA, Johnson SA, Chatfield MD, Cheng AC, Fowler VG Jr, Howden BP, Meagher N, Price DJ, van Hal SJ, O'Sullivan MVN, Davis JS; Australasian Society for Infectious Diseases Clinical Research Network.

JAMA. 2020 Feb 11;323(6):527-537. doi: 10.1001/jama.2020.0103.

PMID:
32044943
3.
4.

Perturbations in Lineage Specification of Granulosa and Theca Cells May Alter Corpus Luteum Formation and Function.

Abedel-Majed MA, Romereim SM, Davis JS, Cupp AS.

Front Endocrinol (Lausanne). 2019 Nov 29;10:832. doi: 10.3389/fendo.2019.00832. eCollection 2019. Review.

5.

Point of care and oral fluid hepatitis B testing in remote Indigenous communities of northern Australia.

Sullivan RP, Davies J, Binks P, Dhurrkay RG, Gurruwiwi GG, Bukulatjpi SM, McKinnon M, Hosking K, Littlejohn M, Jackson K, Locarnini S, Davis JS, Tong SYC.

J Viral Hepat. 2019 Nov 29. doi: 10.1111/jvh.13243. [Epub ahead of print]

PMID:
31785060
6.

Consequences of chemotherapeutic agents on primordial follicles and future clinical applications.

Kim SY, Cho GJ, Davis JS.

Obstet Gynecol Sci. 2019 Nov;62(6):382-390. doi: 10.5468/ogs.2019.62.6.382. Epub 2019 Oct 11. Review.

7.
8.

Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.

Advani SM, Advani PS, Brown DW, DeSantis SM, Korphaisarn K, VonVille HM, Bressler J, Lopez DS, Davis JS, Daniel CR, Sarshekeh AM, Braithwaite D, Swartz MD, Kopetz S.

BMC Cancer. 2019 Oct 17;19(1):964. doi: 10.1186/s12885-019-6144-9.

9.

Use of a multiagency approach to eradicate New World screwworm flies from Big Pine Key, Florida, following an outbreak of screwworm infestation (September 2016-March 2017).

Hennessey MJ, Hsi DJ, Davis JS, Delgado AH, Allen HA, Jandegian CM, Skoda SR, Guerena Watts K, Gibbs SEJ, Powell B, Welch JB, Phillips PL, Kitchen DL, Christy GS, Bonilla DL.

J Am Vet Med Assoc. 2019 Oct 15;255(8):908-914. doi: 10.2460/javma.255.8.908.

PMID:
31573861
10.

At the center of cervical carcinogenesis: synergism between high-risk HPV and the hyperactivated YAP1.

Wang C, Davis JS.

Mol Cell Oncol. 2019 May 23;6(5):e1612677. doi: 10.1080/23723556.2019.1612677. eCollection 2019.

PMID:
31528691
11.

CRyptOcoccosis in Newcastle and the hUnTer (CRONUT) - An epidemiological study.

Hughes CM, Lennon D, Davis JS.

Infect Dis Health. 2020 Feb;25(1):34-42. doi: 10.1016/j.idh.2019.08.003. Epub 2019 Sep 26.

PMID:
31501070
12.

Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma.

Korphaisarn K, Morris V, Davis JS, Overman MJ, Fogelman DR, Kee BK, Dasari A, Raghav KPS, Shureiqi I, Trupti M, Wolff RA, Eng C, Menter DG, Hamilton S, Kopetz S.

Br J Cancer. 2019 Sep;121(6):505-510. doi: 10.1038/s41416-019-0548-9. Epub 2019 Aug 13.

PMID:
31406299
13.

Combination Therapy for MRSA Bacteremia: To β or Not to β?

Holland TL, Davis JS.

Clin Infect Dis. 2019 Aug 12. pii: ciz750. doi: 10.1093/cid/ciz750. [Epub ahead of print] No abstract available.

PMID:
31404470
14.

Yes-associated protein 1 is required for proliferation and function of bovine granulosa cells in vitro†.

Plewes MR, Hou X, Zhang P, Liang A, Hua G, Wood JR, Cupp AS, Lv X, Wang C, Davis JS.

Biol Reprod. 2019 Nov 21;101(5):1001-1017. doi: 10.1093/biolre/ioz139.

15.

Infectious Diseases Clinician's Variation in the Management of Pediatric Staphylococcus aureus Bacteraemia and Equipoise for Clinical Trials.

Campbell AJ, Tong SYC, Davis JS, Munro APS, Blyth CC, Bowen AC.

Front Pediatr. 2019 Jun 18;7:249. doi: 10.3389/fped.2019.00249. eCollection 2019.

16.

Australia's response to the global threat of antimicrobial resistance: past, present and future.

Davis JS, Jones CA, Cheng AC, Howden BP.

Med J Aust. 2019 Aug;211(3):106-108.e1. doi: 10.5694/mja2.50264. Epub 2019 Jul 16. No abstract available.

PMID:
31313300
17.

Whole-Genome Sequencing to Differentiate Relapse From Reinfection in Community-Onset Bacteremic Acinetobacter baumannii Pneumonia.

Meumann EM, Anstey NM, Currie BJ, Piera KA, Baird R, Sarovich DS, Davis JS.

Open Forum Infect Dis. 2019 Jun 1;6(7):ofz263. doi: 10.1093/ofid/ofz263. eCollection 2019 Jul.

18.

The false dichotomy of viral versus bacterial aetiology in upper respiratory tract infections.

Davis JS, Magin PJ, van Driel ML.

Med J Aust. 2019 Aug;211(3):108-109.e1. doi: 10.5694/mja2.50250. Epub 2019 Jun 24. No abstract available.

PMID:
31232463
19.

Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung Cancer.

Davis JS, Prophet E, Peng HL, Lee HY, Tidwell RSS, Lee JJ, Thomas A, Szabo E, Chang S.

JNCI Cancer Spectr. 2019 Jun;3(2):pkz010. doi: 10.1093/jncics/pkz010. Epub 2019 Apr 15.

20.

Defining and Evaluating Patient-Empowered Approaches to Improving Record Matching.

Rudin RS, Hillestad R, Ridgely MS, Qureshi NS, Davis JS 2nd, Fischer SH.

Rand Health Q. 2019 May 16;8(3):3. eCollection 2019 May.

21.

Timely expression and activation of YAP1 in granulosa cells is essential for ovarian follicle development.

Lv X, He C, Huang C, Wang H, Hua G, Wang Z, Zhou J, Chen X, Ma B, Timm BK, Maclin V, Dong J, Rueda BR, Davis JS, Wang C.

FASEB J. 2019 Sep;33(9):10049-10064. doi: 10.1096/fj.201900179RR. Epub 2019 Jun 14.

PMID:
31199671
22.

CASSETTE-clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation: study protocol for a randomised controlled trial.

Dotel R, Tong SYC, Bowen A, Nelson JN, O'Sullivan MVN, Campbell AJ, McMullan BJ, Britton PN, Francis JR, Eisen DP, Robinson O, Manning L, Davis JS.

Trials. 2019 Jun 13;20(1):353. doi: 10.1186/s13063-019-3452-y.

23.

Benzylpenicillin versus flucloxacillin for penicillin-susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study.

Henderson A, Harris P, Hartel G, Paterson D, Turnidge J, Davis JS, Tong SYC.

Int J Antimicrob Agents. 2019 Oct;54(4):491-495. doi: 10.1016/j.ijantimicag.2019.05.020. Epub 2019 Jun 7.

PMID:
31181352
24.

Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates in New South Wales, Australia, 2012-2017.

Dotel R, O'Sullivan MVN, Davis JS, Newton PJ, Gilbert GL.

Infect Dis Health. 2019 Aug;24(3):134-140. doi: 10.1016/j.idh.2019.04.002. Epub 2019 May 13.

PMID:
31097401
25.

Duration of therapy recommended for bacteraemic illness varies widely amongst clinicians.

Alwan M, Davis JS, Daneman N, Fowler R, Shehabi Y, Rogers B.

Int J Antimicrob Agents. 2019 Aug;54(2):184-188. doi: 10.1016/j.ijantimicag.2019.05.011. Epub 2019 May 11.

PMID:
31085297
26.

A Survey of Infectious Diseases and Microbiology Clinicians in Australia and New Zealand About the Management of Staphylococcus aureus Bacteremia.

Tong SYC, Campbell A, Bowen AC, Davis JS.

Clin Infect Dis. 2019 Oct 30;69(10):1835-1836. doi: 10.1093/cid/ciz275. No abstract available.

PMID:
30953050
27.

Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia.

Weis S, Kesselmeier M, Davis JS, Morris AM, Lee S, Scherag A, Hagel S, Pletz MW.

Clin Microbiol Infect. 2019 Jul;25(7):818-827. doi: 10.1016/j.cmi.2019.03.010. Epub 2019 Mar 27.

28.

Vital sign patterns before shock-related cardiopulmonary arrest.

Davis JS, Johns JA, Olvera DJ, Wolfe AC, Gragossian A, Rees EM, Pillar EA, Davis DP.

Resuscitation. 2019 Jun;139:337-342. doi: 10.1016/j.resuscitation.2019.03.028. Epub 2019 Mar 26.

PMID:
30926452
29.

A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.

Lipman J, Brett SJ, De Waele JJ, Cotta MO, Davis JS, Finfer S, Glass P, Knowles S, McGuinness S, Myburgh J, Paterson DL, Peake S, Rajbhandari D, Rhodes A, Roberts JA, Shirwadkar C, Starr T, Taylor C, Billot L, Dulhunty JM.

Crit Care Resusc. 2019 Mar;21(1):63-68.

PMID:
30857514
30.

Tracing Ancient Human Migrations into Sahul Using Hepatitis B Virus Genomes.

Yuen LKW, Littlejohn M, Duchêne S, Edwards R, Bukulatjpi S, Binks P, Jackson K, Davies J, Davis JS, Tong SYC, Locarnini S.

Mol Biol Evol. 2019 May 1;36(5):942-954. doi: 10.1093/molbev/msz021.

PMID:
30856252
31.

A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical Carcinogenesis.

He C, Lv X, Huang C, Angeletti PC, Hua G, Dong J, Zhou J, Wang Z, Ma B, Chen X, Lambert PF, Rueda BR, Davis JS, Wang C.

Cell Rep. 2019 Mar 5;26(10):2636-2650.e5. doi: 10.1016/j.celrep.2019.02.004.

32.

Genomic epidemiology of severe community-onset Acinetobacter baumannii infection.

Meumann EM, Anstey NM, Currie BJ, Piera KA, Kenyon JJ, Hall RM, Davis JS, Sarovich DS.

Microb Genom. 2019 Mar;5(3). doi: 10.1099/mgen.0.000258. Epub 2019 Feb 26.

33.

YAP1-LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis.

He C, Lv X, Huang C, Hua G, Ma B, Chen X, Angeletti PC, Dong J, Zhou J, Wang Z, Rueda BR, Davis JS, Wang C.

EMBO Rep. 2019 Mar;20(3). pii: e44948. doi: 10.15252/embr.201744948. Epub 2019 Feb 12.

PMID:
30755404
34.

Back to the Colorectal Cancer Consensus Molecular Subtype Future.

Menter DG, Davis JS, Broom BM, Overman MJ, Morris J, Kopetz S.

Curr Gastroenterol Rep. 2019 Jan 30;21(2):5. doi: 10.1007/s11894-019-0674-9. Review.

35.

Real-Time Interrogation of Aspirin Reactivity, Biochemistry, and Biodistribution by Hyperpolarized Magnetic Resonance Spectroscopy.

Zacharias NM, Ornelas A, Lee J, Hu J, Davis JS, Uddin N, Pudakalakatti S, Menter DG, Karam JA, Wood CG, Hawk ET, Kopetz S, Vilar E, Bhattacharya PK, Millward SW.

Angew Chem Int Ed Engl. 2019 Mar 22;58(13):4179-4183. doi: 10.1002/anie.201812759. Epub 2019 Feb 20.

36.

Lifestyle behavior patterns and mortality among adults in the NHANES 1988-1994 population: A latent profile analysis.

Davis JS, Banfield E, Lee HY, Peng HL, Chang S, Wood AC.

Prev Med. 2019 Mar;120:131-139. doi: 10.1016/j.ypmed.2019.01.012. Epub 2019 Jan 18.

PMID:
30660707
37.

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.

Varkaris A, Katsiampoura A, Davis JS, Shah N, Lam M, Frias RL, Ivan C, Shimizu M, Morris J, Menter D, Overman M, Tran H, Heymach J, Chun YS, Vauthey JN, Calin G, Kopetz S.

Br J Cancer. 2019 Feb;120(3):340-345. doi: 10.1038/s41416-018-0360-y. Epub 2019 Jan 14.

38.

Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection.

Doernberg SB, Tran TTT, Tong SYC, Paul M, Yahav D, Davis JS, Leibovici L, Boucher HW, Corey GR, Cosgrove SE, Chambers HF, Fowler VG, Evans SR, Holland TL; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2019 May 2;68(10):1691-1698. doi: 10.1093/cid/ciy766.

39.

Adjunctive protein synthesis inhibitor antibiotics for toxin suppression in Staphylococcus aureus infections: a systematic appraisal.

Campbell AJ, Dotel R, Blyth CC, Davis JS, Tong SYC, Bowen AC.

J Antimicrob Chemother. 2019 Jan 1;74(1):1-5. doi: 10.1093/jac/dky387.

PMID:
30307507
40.

The effect of curing hepatitis C with direct-acting antiviral treatment on endothelial function.

Davis JS, Young M, Lennox S, Jones T, Piera K, Pickles R, Oakley S.

Antivir Ther. 2018;23(8):687-694. doi: 10.3851/IMP3257.

PMID:
30048244
41.

In Vivo and In Vitro Impact of Carbohydrate Variation on Human Follicle-Stimulating Hormone Function.

Bousfield GR, May JV, Davis JS, Dias JA, Kumar TR.

Front Endocrinol (Lausanne). 2018 May 9;9:216. doi: 10.3389/fendo.2018.00216. eCollection 2018. Review.

42.

Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.

Cheah BC, Davies J, Singh GR, Wood N, Jackson K, Littlejohn M, Davison B, McIntyre P, Locarnini S, Davis JS, Tong SYC.

Vaccine. 2018 Jun 7;36(24):3533-3540. doi: 10.1016/j.vaccine.2018.01.062. Epub 2018 May 4.

PMID:
29735323
43.

Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer.

Loree JM, Bailey AM, Johnson AM, Yu Y, Wu W, Bristow CA, Davis JS, Shaw KR, Broaddus R, Banks KC, Lanman RB, Meric-Bernstam F, Overman MJ, Kopetz S, Raghav K.

J Natl Cancer Inst. 2018 Dec 1;110(12):1409-1417. doi: 10.1093/jnci/djy067.

44.

Triennial Reproduction Symposium: Looking back and moving forward-how reproductive physiology has evolved.

Hamernik DL, Cupp AS, Davis JS.

J Anim Sci. 2018 Jun 29;96(7):2949-2951. doi: 10.1093/jas/sky148. No abstract available.

45.

The unique aspects of chronic hepatitis B infection in Aboriginal and Torres Strait Islander people.

Davies J, Boutlis CS, Marshall CS, Tong SYC, Davis JS.

Intern Med J. 2018 Apr;48(4):484-485. doi: 10.1111/imj.13759. No abstract available.

PMID:
29623985
46.

Epidemiology, Microbiological Diagnosis, and Clinical Outcomes in Pyogenic Vertebral Osteomyelitis: A 10-year Retrospective Cohort Study.

Chong BSW, Brereton CJ, Gordon A, Davis JS.

Open Forum Infect Dis. 2018 Mar 10;5(3):ofy037. doi: 10.1093/ofid/ofy037. eCollection 2018 Mar.

47.

Proof of concept study of a novel pacemapping algorithm as a basis to guide ablation of ventricular arrhythmias.

Li A, Davis JS, Grimster A, Wierwille J, Herold K, Morgan D, Behr ER, Shorofsky S, Saba M.

Europace. 2018 Oct 1;20(10):1647-1656. doi: 10.1093/europace/euy024.

PMID:
29528391
48.

Adalimumab for Corticosteroid and Infliximab-Resistant Immune Reconstitution Inflammatory Syndrome in the Setting of TB/HIV Coinfection.

Lwin N, Boyle M, Davis JS.

Open Forum Infect Dis. 2018 Jan 30;5(2):ofy027. doi: 10.1093/ofid/ofy027. eCollection 2018 Feb.

49.

Hot topics in necrotising skin and soft tissue infections.

Saeed K, Esposito S, Gould I, Ascione T, Bassetti M, Bonnet E, Bouza E, Chan M, Davis JS, De Simone G, Dryden M, Gottlieb T, Hijazi K, Lye DC, Pagliano P, Petridou C, Righi E, Segreti J, Unal S, Yalcin AN; International Society of Antimicrobial Chemotherapy.

Int J Antimicrob Agents. 2018 Jul;52(1):1-10. doi: 10.1016/j.ijantimicag.2018.02.012. Epub 2018 Mar 6. Review. No abstract available.

PMID:
29501822
50.

A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.

Davis JS, Turnidge J, Tong S.

Int J Antimicrob Agents. 2018 Aug;52(2):297-300. doi: 10.1016/j.ijantimicag.2018.02.013. Epub 2018 Feb 28.

PMID:
29499317

Supplemental Content

Loading ...
Support Center